Sabra Health Care REIT, Inc.
SBRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.75 | 0.26 | -1.72 | 0.41 |
| FCF Yield | 2.24% | 1.84% | 1.93% | 1.95% |
| EV / EBITDA | 68.60 | 49.55 | 58.86 | 51.77 |
| Quality | ||||
| ROIC | 1.07% | 1.37% | 1.30% | 1.29% |
| Gross Margin | 63.35% | 67.70% | 67.35% | 67.18% |
| Cash Conversion Ratio | 4.44 | 1.24 | 1.99 | 1.71 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.55% | 10.62% | 10.45% | 9.75% |
| Free Cash Flow Growth | 23.47% | 0.87% | 0.37% | -18.11% |
| Safety | ||||
| Net Debt / EBITDA | 24.04 | 17.56 | 21.53 | 19.04 |
| Interest Coverage | 0.00 | 2.61 | 2.49 | 2.40 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 53.62 | 73.76 | 61.97 | 65.03 |